↓ Skip to main content

Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
39 X users
patent
3 patents
wikipedia
13 Wikipedia pages

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
151 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies
Published in
Orphanet Journal of Rare Diseases, May 2020
DOI 10.1186/s13023-020-01379-8
Pubmed ID
Authors

Thomas Opladen, Eduardo López-Laso, Elisenda Cortès-Saladelafont, Toni S. Pearson, H. Serap Sivri, Yilmaz Yildiz, Birgit Assmann, Manju A. Kurian, Vincenzo Leuzzi, Simon Heales, Simon Pope, Francesco Porta, Angeles García-Cazorla, Tomáš Honzík, Roser Pons, Luc Regal, Helly Goez, Rafael Artuch, Georg F. Hoffmann, Gabriella Horvath, Beat Thöny, Sabine Scholl-Bürgi, Alberto Burlina, Marcel M. Verbeek, Mario Mastrangelo, Jennifer Friedman, Tessa Wassenberg, Kathrin Jeltsch, Jan Kulhánek, Oya Kuseyri Hübschmann

X Demographics

X Demographics

The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 151 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 13%
Student > Ph. D. Student 19 13%
Student > Bachelor 16 11%
Student > Master 10 7%
Student > Doctoral Student 8 5%
Other 22 15%
Unknown 56 37%
Readers by discipline Count As %
Medicine and Dentistry 25 17%
Biochemistry, Genetics and Molecular Biology 19 13%
Neuroscience 13 9%
Agricultural and Biological Sciences 7 5%
Nursing and Health Professions 6 4%
Other 21 14%
Unknown 60 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2024.
All research outputs
#1,194,781
of 25,732,188 outputs
Outputs from Orphanet Journal of Rare Diseases
#126
of 3,179 outputs
Outputs of similar age
#34,976
of 430,573 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 56 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,179 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.